Microplastics in the Placenta: What Do Pregnancy Studies Show?

Several studies have detected plastic material in human placentas using Raman spectroscopy, infrared imaging, and Py-GC/MS. That establishes placental presence under multiple methods, but it does not establish a safe or harmful dose. Emerging studies report associations with miscarriage and newborn size, while causation and the extent of maternal-to-fetal particle transfer remain uncertain.

Quick answer

Microplastics and polymer mass have been reported in human placental or gestational samples. The strongest conclusion is detection, not proof of harm.

Finding material in the placenta does not automatically mean it crossed into fetal circulation. Human outcome studies are observational, and experimental transfer depends heavily on particle size, label, dose, animal model, and exposure route. There is no validated placental reference range, pregnancy test, or treatment based on a microplastic result.

For the wider evidence picture, start with PFK's microplastics and human health guide.

Three things to know

• Placental detection has been reported with several methods: Particle-level spectroscopy and mass-based chemical analysis provide different, partly converging evidence.
• Detection does not prove fetal transfer: The placenta can receive, retain, or restrict material, and its fetal side is still placental tissue.
• Pregnancy-outcome evidence is emerging: Studies have reported associations with miscarriage and smaller birth measurements, but they do not establish that microplastics caused those outcomes.

How the main claims hold up

Claim 1: Have microplastics been found in human placentas?

PFK verdict: Yes, although the method changes what “found” means.

A first report examined six placentas with Raman microspectroscopy and described 12 fragments measuring 5 to 10 micrometres in four samples. Three were identified as stained polypropylene. The other nine were characterised mainly by industrial pigments, so their polymer identity was less certain. The study sampled only a small fraction of each placenta and included no outcome comparison.

A 2024 study processed 62 placentas with Py-GC/MS and reported polymer mass in every sample, ranging from 6.5 to 685 micrograms per gram of tissue. Polyethylene made up 54% of measured mass.

Py-GC/MS is useful for quantifying selected polymers, but it destroys the sample. It cannot show the number, intactness, size, shape, or original location of particles. Particle counts from imaging should not be compared directly with polymer mass from Py-GC/MS.

Claim 2: Does placental detection prove that particles reached the fetus?

PFK verdict: No. Transfer is biologically possible in experiments, but placental presence alone cannot demonstrate it.

A rat study published online in 2025 orally exposed pregnant animals to europium-labelled 0.2-micrometre and 2-micrometre particles from gestational day 0.5 to 18.5. It reported size-dependent maternal-to-fetal transfer, including a placenta-to-fetus transfer rate of 0.48% for the smaller condition.

An important counterweight comes from a 2026 mouse study using unmodified polystyrene with covalent carbon-14 backbone labels. After intranasal exposure, researchers detected no polystyrene in placentas or fetuses. After direct intravenous exposure, placental concentrations were low, at 0.10% to 0.15% of the injected dose.

These are different experiments, not competing estimates of normal human transfer. Route, size, dose, and label integrity can change where administered particles go.

A 2026 report also described Raman-identified particles in organs from six fetuses at about 22 weeks' gestation. All cases involved intrauterine death or congenital defects, there was no healthy comparison group, and one reported particle measured 897 micrometres. That unusual finding and the contamination challenge make the study hypothesis-generating, not confirmation of widespread fetal exposure.

Claim 3: Are placental microplastics associated with pregnancy outcomes?

PFK verdict: Emerging human studies report associations, not causation.

A 2025 study compared first-trimester chorionic villi from 18 unexplained spontaneous miscarriages with 13 elective terminations of otherwise progressing pregnancies. Total polymer mass was higher in the miscarriage group, averaging 273.08 versus 226.37 micrograms per gram.

The tissue was collected after the outcome, the sample was small, and residual confounding or reverse causation could explain part of the difference. The result does not show that microplastics increased miscarriage risk.

A much larger study recruited 1,750 mother-infant pairs in China between 2022 and 2024. Researchers used laser direct infrared imaging on maternal and fetal sides of placentas collected at delivery. Higher total and polymer-specific particle counts were associated with lower birth weight, length, and head circumference. The adjusted estimate for total microplastics was 107.7 grams lower birth weight, with several mixture models showing similar patterns.

The size of this cohort is a strength, but placental measurements and birth outcomes were available at delivery. The observational analysis cannot establish exposure timing, causal direction, or whether unmeasured social, dietary, medical, or environmental factors influenced both results. A group-average difference also does not define harm for an individual baby.

Claim 4: Is there a harmful placental level or a useful pregnancy test?

PFK verdict: No validated clinical threshold or test exists.

Research laboratories use different tissue preparation, size cutoffs, polymer targets, units, and contamination controls. A result in particles per 10 grams cannot be converted into micrograms per gram without assumptions about particle size, shape, and density.

No reference range tells clinicians what placental measurement is safe or harmful, and research methods do not guide pregnancy management.

Practical implications

Pregnant people should not change prenatal care, nutrition, hydration, or medically recommended products because of these studies. Questions about pregnancy should go to a qualified prenatal health professional.

Reducing avoidable plastic contact can still be a personal, low-regret choice. If practical, use suitable glass, ceramic, or stainless steel for frequently heated food and drinks, and replace heavily worn plastic food-contact items over time. PFK's guide to what to replace first in a lower-plastic kitchen offers a gradual approach.

These steps may reduce specific contact opportunities. They have not been shown to prevent miscarriage, change placental measurements, improve fetal growth, or guarantee fetal protection.

Pregnancy and placental evidence is separate from research on sperm, ovarian reserve, fertilisation, and fertility.

PFK assessment: Placental detection is supported by several analytical approaches, but the evidence does not yet provide a causal pregnancy-risk estimate, prove fetal transfer from placental detection, or create a clinical test.

How PFK evaluated these claims

PFK separated placental detection, maternal-to-fetal transfer, pregnancy-outcome associations, and clinical action. We checked whether each method measured particles or polymer mass, how samples were collected, whether contamination controls were described, when exposure was measured, and whether the design could establish direction or cause.

This keeps converging detection evidence from being overstated as proof of fetal harm.

Research reviewed August 1, 2026. This article is for educational purposes and is not medical advice. Speak with a qualified prenatal health professional about pregnancy concerns or care decisions.

Sources

1. Ragusa A, Svelato A, Santacroce C, Catalano P, et al. “Plasticenta: First evidence of microplastics in human placenta.” Environment International. 2021;146:106274. DOI: 10.1016/j.envint.2020.106274. PMID: 33395930.
2. Garcia MA, Liu R, Nihart A, El Hayek E, et al. “Quantitation and identification of microplastics accumulation in human placental specimens using pyrolysis gas chromatography mass spectrometry.” Toxicological Sciences. 2024. DOI: 10.1093/toxsci/kfae021. PMID: 38366932.
3. Wang P, Li G, Shou H, Huang X, et al. “Microplastic abundance in placental chorionic villi detected by pyrolysis-gas chromatography/mass spectrometry in cases of spontaneous miscarriage during early pregnancy.” eBioMedicine. 2025;120:105918. DOI: 10.1016/j.ebiom.2025.105918. PMID: 40972227.
4. Shen Y, Ning Y, Chen F, Wang X, et al. “Impact of placental microplastics on birth anthropometrics: A cross-sectional study.” Ecotoxicology and Environmental Safety. 2026. DOI: 10.1016/j.ecoenv.2025.119572. PMID: 41499815.
5. Feng Y, Wu D, Guan Q, Wang Q, et al. “Quantification and visualization of micro- and nano-plastics transfer from maternal to fetal: A rat model study.” Journal of Hazardous Materials. 2026;502:140628. Published online November 26, 2025. DOI: 10.1016/j.jhazmat.2025.140628. PMID: 41313868.
6. Khaybullina O, Sarkhel P, Keinänen OM. “Tracking of [14C]Polystyrene Nanoplastics in Pregnant Mice.” Advanced Science. 2026. DOI: 10.1002/advs.202523995. PMID: 41875353.
7. Zhang R, Zhou YI, Zhao X, Chen Q, et al. “Identification and analysis of microplastics in main organs of human fetus.” Ecotoxicology and Environmental Safety. 2026;314:120078. DOI: 10.1016/j.ecoenv.2026.120078. PMID: 41905030.
8. Dmitrowicz A, Sacharczuk M, Skiba D. “Micro- and nanoplastics in human biological materials: a systematic review of detection methods and methodological challenges.” Archives of Toxicology. 2026. DOI: 10.1007/s00204-026-04392-1.